{"nct_id":"NCT03530683","title":"A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma","status":"TERMINATED","status_verified_date":"2024-08","start_date":"2018-05-14","start_date_type":"ACTUAL","primary_completion_date":"2024-07-18","primary_completion_date_type":"ACTUAL","completion_date":"2024-07-18","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["PFE"]}